June 29, 2018 / 12:02 PM / 19 days ago

BRIEF-EMA Recommendations For June 2018

June 29 (Reuters) - EU Medicines Agency:

* EMA RECOMMENDATIONS FOR JUNE 2018

* EMA RECOMMENDS APPROVAL OF NOVARTIS GENE-BASED CELL THERAPY KYMRIAH

* EMA RECOMMENDS APPROVAL OF BAXALTA’ INNOVATIONS’ DRUG FOR VON WILLEBRAND DISEASE VONICOG ALFA

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF ULTRAGENYX DRUG FOR TREATMENT OF SLY SYNDROME

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF GILEAD SCIENCES' CAR-T TREATMENT FOR ADVANCED NON-HODGKIN LYMPHOMA YESCARTA Source text ID: (bit.ly/2Ky9Rwj) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below